Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

The Manila Times
manilatimes.net > 09/09/2026 > tmt-newswire > globenewswire > vianautis-bio-welcomes-sci-ventures-as-new-investor-expanding-cns-portfolio-into-spinal-cord-injury > 2421230

ViaNautis Bio welcomes SCI Ventures as new investor, expanding CNS portfolio into spinal cord injury

5+ day, 4+ hour ago   (468+ words) Investment supports application of ViaNautis’ polyNaut® platform to regenerative therapies for spinal cord injury, where targeted delivery remains a huge barrierAdds a new high-value CNS indication and provides further validation of polyNaut® as a versatile platform for precise, non-viral delivery…...

The Manila Times
manilatimes.net > 09/09/2026 > tmt-newswire > globenewswire > genfit-highlights-long-term-commercial-opportunity-for-its-mash-diagnostics-technology > 2421187

GENFIT Highlights Long-Term Commercial Opportunity for its MASH Diagnostics Technology

5+ day, 6+ hour ago   (200+ words) The Commercial Opportunity for GENFIT Beyond the United States - In Europe and Asia, GENFIT expects its IVD2 strategy to play a key role in the future commercialization of its NISTM Technology. Supported by the anticipated expansion of the MASH therapeutic market…...

The Manila Times
manilatimes.net > 09/08/2026 > tmt-newswire > globenewswire > neurostar-advances-practice-innovation-with-first-ever-tms-integration-with-an-ehremr-system > 2420620

NeuroStar Advances Practice Innovation with First-Ever TMS Integration with an EHR/EMR System

5+ day, 23+ hour ago   (660+ words) The Manila Times NeuroStar Advances Practice Innovation with First-Ever TMS Integration with an EHR/EMR System First-of-Its-Kind Integration Connects TrakStar and AdvancedMD, Delivering TMS Care Across Clinical, Operational, and Billing Workflows MALVERN, Pa., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM),…...

The Manila Times
manilatimes.net > 09/09/2026 > tmt-newswire > globenewswire > inventiva-to-present-multiple-abstracts-at-paris-mash-2026 > 2421022

Inventiva to Present Multiple Abstracts at Paris MASH 2026

5+ day, 15+ hour ago   (330+ words) Phase 1 and Phase 2 clinical data showed lanifibranor improves metabolic profile and cardiovascular risk factors in patients with MASH with or without type 2 diabetesPreclinical data further characterize lanifibranor’s balanced pan-PPAR pharmacology and support a differentiated fluid and cardiac profile relative to…...

The Manila Times
manilatimes.net > 09/09/2026 > tmt-newswire > globenewswire > maverick-medical-ai-brings-revenue-certainty-to-the-hospital-revenue-cycle > 2421025

Maverick Medical AI Brings Revenue Certainty to the Hospital Revenue Cycle

5+ day, 15+ hour ago   (237+ words) The Manila Times Maverick Medical AI Brings Revenue Certainty to the Hospital Revenue Cycle Clinical-to-Revenue Intelligence identifies and addresses revenue-impacting issues from the point of care through claim submission, before they reach the payer WILMINGTON, Del., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Maverick…...

The Manila Times
manilatimes.net > 09/09/2026 > tmt-newswire > globenewswire > radicle-science-expands-leadership-across-science-data-and-health-economics-for-precision-wellness > 2421047

Radicle Science Expands Leadership Across Science, Data, and Health Economics for Precision Wellness

5+ day, 15+ hour ago   (261+ words) Three new scientific leaders and the appointment of former White House Chief Healthcare Economist Jonathan Ketcham, PhD, to the advisory board deepen Radicle’s ability to turn rigorous evidence into precision insights, better health outcomes and measurable economic value SAN DIEGO,…...

The Manila Times
manilatimes.net > 09/09/2026 > tmt-newswire > globenewswire > healthex-empowers-consumers-to-bring-their-personal-health-history-to-muse-metas-new-personal-ai-agent > 2421017

HealthEx Empowers Consumers to Bring Their Personal Health History to Muse, Meta???s New Personal AI Agent

5+ day, 15+ hour ago   (538+ words) HealthEx Empowers Consumers to Bring Their Personal Health History to Muse, Meta’s New Personal AI Agent The Manila Times HealthEx Empowers Consumers to Bring Their Personal Health History to Muse, Meta’s New Personal AI Agent Americans can connect their health…...

The Manila Times
manilatimes.net > 09/08/2026 > tmt-newswire > globenewswire > new-multi-site-validation-study-published-by-panakeia-reinforces-scalability-of-ai-multi-omics-platform > 2420225

New Multi-Site Validation Study Published by Panakeia Reinforces Scalability of AI Multi-Omics Platform

6+ day, 4+ hour ago   (143+ words) Study confirms diagnostic-grade performance of PANProfiler Breast (ER, PR, HER2) from routine brightfield images; establishing the technology as a scalable foundation for oncology across multiple cancer types and biomarkers These findings build upon the platform's established success in colorectal cancer (PANProfiler…...

The Manila Times
manilatimes.net > 09/08/2026 > tmt-newswire > globenewswire > from-smart-massage-to-proactive-wellness-skg-expands-its-wearable-health-portfolio-at-ifa-2026 > 2420246

From Smart Massage to Proactive Wellness: SKG Expands Its Wearable Health Portfolio at IFA 2026

6+ day, 3+ hour ago   (283+ words) BERLIN, Sept. 08, 2026 (GLOBE NEWSWIRE) -- SKG Health is showcasing an expanded portfolio of wearable health products at IFA 2026, highlighting its move from portable massage into recovery, training support and proactive health monitoring. International media and visitors from Germany and across Europe…...

The Manila Times
manilatimes.net > 09/08/2026 > tmt-newswire > globenewswire > nyxoah-announces-first-patient-implanted-in-breathe-the-us-post-approval-study-of-the-genio-system > 2420067

Nyxoah Announces First Patient Implanted in BREATHE, the U.S. Post-Approval Study of the Genio® System

6+ day, 15+ hour ago   (135+ words) BREATHE is scheduled to implant up to 229 patients at up to 25 U.S. centers, followed for up to five years, to evaluate the long-term safety and effectiveness of the Genio therapy in real-world clinical practice First implant performed by Rolando Molina, MD,…...